Protective immunization against melanoma by gp100 DNA-HVJ-liposome vaccine

Gene Therapy

Volumn 6, Issue 10, 1999, Pages 1768-1773

  Zhou, W Z ^a   Kaneda, Y ^a   Huang, S K S ^b   Morishita, R ^a   Hoon, D S B ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

Gene therapy; Gp100; Liposome; Melanoma vaccine

Indexed keywords

ANTIBODY; DNA VACCINE; LIPOSOME; MELANOMA VACCINE; PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CANCER SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; IMMUNE RESPONSE; IMMUNIZATION; MALE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, NEOPLASM; CANCER VACCINES; GENE THERAPY; IMMUNIZATION; INJECTIONS, INTRAMUSCULAR; LIPOSOMES; MALE; MELANOMA, EXPERIMENTAL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; RESPIROVIRUS; SKIN NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA;

EID: 0032863158     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300998     Document Type: Article

References (24)

1. Ho TY et al. DNA vaccination induces a long-term antibody response and protective immunity against pseudorabies virus in mice. Arch Virol 1998; 143: 115-125.
2. Larsen DL et al. Coadminstration of DNA encoding interleukin-6 and hemagglutinin confers protection from influenza virus challenge in mice. J Virol 1998; 72: 1704-1708.
3. Iwasaki A, Barber BH. Induction by DNA immunization of a protective antitumor cytotoxic T lymphocyte response against a minimal-epitope-expressing tumor. Cancer Immunol Immunother 1994; 45: 273-279.
4. Chen Y et al. DNA vaccines encoding full-length or truncated Neu induce protective immunity against Neu-expressing mammary tumors. Cancer Res 1998; 58: 1965-1971.
5. Schreurs MWJ, de Boer A, Figdor CG, Adema GJ. Genetic vaccination against the melanocyte lineage-specific antigen gp100 induces cytotoxic T lymphocyte-mediated protection. Cancer Res 1998; 58: 2509-2514.
6. Kawakami Y et al. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Pror Natl Acad Sci USA 1994; 91: 6458-6462.
7. Zhai Y et al. Antigen-specific tumor vaccines: development and characterization of recombinant adenoviruses encoding MART1 or gp100 for cancer therapy. J Immunol 1996; 156: 700-710.
8. Huang SKS et al. Antibody responses to melanoma/melanocyte auto-antigens in melanoma patients. J Invest Dermatol 1998; 111: 662-667.
9. Zhai Y et al. Cloning and characterization of the genes encoding the mouse homologues of the human melanoma antigen MART 1 and gp100. J Immunother 1997; 20: 15-25.
10. Sarantou T et al. Melanoma-associated antigen as messenger RNA detection markers for melanoma. Cancer Res 1997; 57: 1371-1376.
11. Okamoto T et al. Induction of antibody response to human tumor antigens by gene therapy using a fusigenic viral liposome vaccine. Gene Therapy 1997; 4: 969-976.
12. Hirano K et al. Persistent gene expression in rat liver in vivo by repetitive transfections using HVJ-liposome. Gene Therapy 1998; 5: 459-464.
13. Saeki Y et al. Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): reciprocal effect of cationic lipid for in vivo and in vitro gene transfer. Hum Gene Ther 1997; 8: 2133-2141.
14. Nakanishi M et al. Efficient induction of contents of liposomes into cells using HVJ (Sendai virus). Exp Cell Res 1985; 159: 399-409.
15. Kaneda Y et al. The improved efficient method for introducing macromolecules into cells using HVJ (Sendai virus) liposomes with gangliosides. Exp Cell Res 1987; 173: 56-69.
16. Kaneda Y Iwai K, Uchida T. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science 1989; 243: 375-378.
17. Kaneda Y, Iwai K, Uchida T. Introduction and expression of the human Insulin gene in adult rat liver. J Biol Chem 1989; 264: 12126-12129.
18. Morishita R et al. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal by perplasia. Proc Natl Acad Sci USA 1993; 90: 8474-8478.
19. Morishita R et al. Novel and effective gene transfer technique for study of vascular renin angiotensin system. J Clin Invest 1993; 91: 2580-2585.
20. Hoon DSB, Irie RF. Current status of human melanoma vaccines. Can they control malignant melanoma? BioDrugs 1997; 1: 66-84.
21. Morton DL et al. Prolongation of survival in metastatic melanoma after active specific immunotherapy with new polyvalent melanoma vaccine. Ann Surg 1992; 216: 463-482.
22. Baniyash M et al. Serologically detectable MHC and tumor-asso4 ciated antigens on B16 melanoma variants and humoral immunity in mice bearing these tumors. J Immunol 1982; 129:1318-1323.
23. Schearer GM, Rehn TG, Garbarino CA. Cell-mediated lympholysis of trinitrophenyl-modified autologous lymphocytes. J Exp Med 1975; 141: 1348-1364.
24. Zinkernagel RM, Dohetry OC. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic chorio-meningitis within a syngenic or semiallogenic system. Nature 1974; 248: 701-702.